chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 54.0
Sex: F
Vaccine: PNC21
Symptoms: Angioedema, Decreased appetite, Fatigue, Injection site erythema, Injection site pain
Clinical narrative: Pt stated she received the imz on 5-31-25, however she noticed her arm started redness, pain upon touch, and muscle hardness today, 6-3-25. It starts at around the injection site and starts about 1 inch wide ffor 2.5 inches and then widens to about 3 inches wide totally goes down her arm about 5 inches. She said it feels warm to the touch and feels like a bruise would feel and her muscle feels hard. Had body aches and a fever and fatigue and no appetite on 6-1-25 and took Tylenol PM. Dr is out of town for a couple of weeks, so we will follow up with another at the clinic. Pt called her doctor's office also and will follow up with them too
Age: 54.0
Sex: F
Vaccine: PNC21
Symptoms: Injection site reaction, Pain
Clinical narrative: Pt stated she received the imz on 5-31-25, however she noticed her arm started redness, pain upon touch, and muscle hardness today, 6-3-25. It starts at around the injection site and starts about 1 inch wide ffor 2.5 inches and then widens to about 3 inches wide totally goes down her arm about 5 inches. She said it feels warm to the touch and feels like a bruise would feel and her muscle feels hard. Had body aches and a fever and fatigue and no appetite on 6-1-25 and took Tylenol PM. Dr is out of town for a couple of weeks, so we will follow up with another at the clinic. Pt called her doctor's office also and will follow up with them too
Age: 1.0
Sex: M
Vaccine: MMR
Symptoms: Expired product administered
Clinical narrative: They gave my 12 month old vaccine that was expired by a month.
Age: 1.0
Sex: M
Vaccine: MMR
Symptoms: Pyrexia, Urticaria
Clinical narrative: High fever 102.3 for two days followed by hives for3 days
Age: 64.0
Sex: M
Vaccine: COVID19
Symptoms: Back pain, Blood test, Central nervous system lesion, Computerised tomogram, Fatigue
Clinical narrative: Pain, fatigue, muscle weakness in legs, difficulty walking, back pain, diagnosis of transverse myelitis with lesions on the spine
Age: 64.0
Sex: M
Vaccine: COVID19
Symptoms: Gait disturbance, Lumbar puncture, Magnetic resonance imaging, Muscular weakness, Myelitis transverse
Clinical narrative: Pain, fatigue, muscle weakness in legs, difficulty walking, back pain, diagnosis of transverse myelitis with lesions on the spine
Age: 64.0
Sex: M
Vaccine: COVID19
Symptoms: Pain, X-ray
Clinical narrative: Pain, fatigue, muscle weakness in legs, difficulty walking, back pain, diagnosis of transverse myelitis with lesions on the spine
Age: 48.0
Sex: M
Vaccine: COVID19, FLU3, TDAP
Symptoms: Expired product administered
Clinical narrative: Patient was given a Covid vaccine that was expired. Vaccine expired 5/8/2025 and given 5/13/2025. Patient unable to communicate through phone well but family member states patient has been doing fine.
Age: 56.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event
Clinical narrative: Patient was given a Covid vaccine that was expired. Vaccine expired 5/8/2025 and given 5/13/2025. Unable to reach patient x 5 times. Per spouse patient has been going to work every day from 4 am with no problems.
Age: 59.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event
Clinical narrative: Patient was given a Covid that was expired. Vaccine expired 5/8/25 and was given 5/13/25. Called patient was was able to reach patient today states he has been doing fine with no complaints.
Age: 48.0
Sex: F
Vaccine: COVID19, FLU3, TDAP
Symptoms: Expired product administered, Injection site pain
Clinical narrative: Patient was given a Covid vaccine that was expired. Vaccine expired 5/8/2025 and given 5/13/2025. Patient complained of arm pain at injection site, no other complaints. Per patient doing well.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Back pain, Injected limb mobility decreased, Injection site pain, Neck pain
Clinical narrative: Site: Pain at Injection Site-Medium, Systemic: pain, swelling across shoulders and back/neck area, limited movement of right arm above shoulder level-Medium
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Swelling
Clinical narrative: Site: Pain at Injection Site-Medium, Systemic: pain, swelling across shoulders and back/neck area, limited movement of right arm above shoulder level-Medium
Age: 16.0
Sex: F
Vaccine: MENB, MNQ, MENB, MNQ
Symptoms: Body temperature increased, Headache, Injection site hypoaesthesia, Injection site pain, Ultrasound scan abnormal
Clinical narrative: could not lift right arm; Pain injection site; numbness, swelling and redness at injection site right arm; could not lift right arm; numbness, swelling and redness at injection site right arm; This non-serious case was reported by a other health professional via call center representative and described the occurrence of injection site pain in a 16-year-old female patient who received Men B NVS (Bexsero) (batch number DD72H) for prophylaxis.   Co-suspect products included Men ACWY-CRM NVS (Menveo) (batch number 3E99M) for prophylaxis.   On 24-APR-2025, the patient received Bexsero (right deltoid) and Menveo (left arm). On 24-APR-2025, several hours after receiving Bexsero and Menveo, the patient experienced injection site pain (Verbatim: Pain injection site), injection site numbness (Verbatim: numbness, swelling and redness at injection site right arm), injection site swelling (Verbatim: could not lift right arm) and injection site erythema (Verbatim: numbness, swelling and redness at injection site right arm). On 25-APR-2025, the patient experienced injected limb mobility decreased (Verbatim: could not lift right arm). The outcome of the injection site pain, injection site numbness, injection site swelling and injection site erythema were resolved and the outcome of the injected limb mobility decreased was unknown.   It was unknown if the reporter considered the injection site pain, injection site numbness, injection site swelling, injection site erythema and injected limb mobility decreased to be related to Bexsero, Bexsero Pre-Filled Syringe Device and Menveo.     It was unknown if the company considered the injection site pain, injection site numbness, injection site swelling, injection site erythema and injected limb mobility decreased to be related to Bexsero, Bexsero Pre-Filled Syringe Device and Menveo.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK Receipt Date: 28-MAY-2025 The reporter reported that the patient had Bexsero in right arm and Menveo in left arm, on 24th April 2025, a few hours later, she experienced right arm, pain, redness, swelling and numbness at injection site. The next day she could not lift right arm. This case US2025066669 reported by same reporter.; Sender's Comments:  US-GSK-US2025066669:1 of 2 report
Age: 16.0
Sex: F
Vaccine: MENB, MNQ, MENB, MNQ
Symptoms: Injected limb mobility decreased, Injection site erythema, Injection site hypoaesthesia, Injection site pain
Clinical narrative: could not lift right arm; Pain injection site; numbness, swelling and redness at injection site right arm; could not lift right arm; numbness, swelling and redness at injection site right arm; This non-serious case was reported by a other health professional via call center representative and described the occurrence of injection site pain in a 16-year-old female patient who received Men B NVS (Bexsero) (batch number DD72H) for prophylaxis.   Co-suspect products included Men ACWY-CRM NVS (Menveo) (batch number 3E99M) for prophylaxis.   On 24-APR-2025, the patient received Bexsero (right deltoid) and Menveo (left arm). On 24-APR-2025, several hours after receiving Bexsero and Menveo, the patient experienced injection site pain (Verbatim: Pain injection site), injection site numbness (Verbatim: numbness, swelling and redness at injection site right arm), injection site swelling (Verbatim: could not lift right arm) and injection site erythema (Verbatim: numbness, swelling and redness at injection site right arm). On 25-APR-2025, the patient experienced injected limb mobility decreased (Verbatim: could not lift right arm). The outcome of the injection site pain, injection site numbness, injection site swelling and injection site erythema were resolved and the outcome of the injected limb mobility decreased was unknown.   It was unknown if the reporter considered the injection site pain, injection site numbness, injection site swelling, injection site erythema and injected limb mobility decreased to be related to Bexsero, Bexsero Pre-Filled Syringe Device and Menveo.     It was unknown if the company considered the injection site pain, injection site numbness, injection site swelling, injection site erythema and injected limb mobility decreased to be related to Bexsero, Bexsero Pre-Filled Syringe Device and Menveo.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK Receipt Date: 28-MAY-2025 The reporter reported that the patient had Bexsero in right arm and Menveo in left arm, on 24th April 2025, a few hours later, she experienced right arm, pain, redness, swelling and numbness at injection site. The next day she could not lift right arm. This case US2025066669 reported by same reporter.; Sender's Comments:  US-GSK-US2025066669:1 of 2 report
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Nasopharyngitis
Clinical narrative: had the lightest cold symptoms with Delta; This spontaneous case was reported by a consumer and describes the occurrence of NASOPHARYNGITIS (had the lightest cold symptoms with Delta) in a 68-year-old female patient who received SPIKEVAX NOS (SPIKEVAX NOS) for COVID-19 prophylaxis.     The patient's past medical history included Pneumonia. Concurrent medical conditions included Asthmatic.    On an unknown date, the patient received dose of SPIKEVAX NOS (SPIKEVAX NOS) (Intramuscular use) 1 dosage form. On an unknown date, the patient experienced NASOPHARYNGITIS (had the lightest cold symptoms with Delta). At the time of the report, NASOPHARYNGITIS (had the lightest cold symptoms with Delta) outcome was unknown.        The action taken with SPIKEVAX NOS (SPIKEVAX NOS) (Intramuscular use) was unknown.       No concomitant medication was reported. The patient was fit athletic. She was asthmatic that easily gets pneumonia from just the common cold. Vaccines helped her greatly not had that reaction. When her dog had surgery, and brought Delta into her home, she lost her 2 cats but had the lightest cold symptoms with Delta that she especially had ever had.  She had bird flu and wild flocks, so she was looking forward to receiving that vaccine. HCP recommended to get the mRna Covid-19 vaccine several times. It was unknown if the patient experienced any additional symptoms or events. Reporter causality was not reported.  No treatment medication was reported.   This case was linked to US-MODERNATX, INC.-MOD-2025-787090 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2025-787090:For male patient
Age: 22.0
Vaccine: RAB
Symptoms: Injection site rash
Clinical narrative: developed rashes around the injection site after the second dose,described the rash to be circular; Initial information received on 02-Jun-2025 regarding an unsolicited valid  non-serious case received from other health professional.  This case involves a 22 years old and unknown gender patient who had developed rashes around the injection site after the second dose,described the rash to be circular after receiving rabies (HDC) vaccine [Imovax rabies].  The patient's past medical history, medical treatment(s), concomitant medications, vaccination(s) and family history were not provided.  On 23-May-2025, the patient received Dose 2 of 1 ml of suspect rabies (HDC) vaccine Powder and solvent for suspension for injection of strength standard and frequency once (Unknown lot and expiry date) via intramuscular route in the left arm for Immunisation.  Information on the batch number was requested corresponding to the one at time of event occurrence.   On 23-May-2025 the patient developed rashes around the injection site after the second dose, described the rash to be circular (vaccination site rash) (Latency same day).  Reportedly, reporter reported that a patient developed rashes around the injection site after the second dose but eventually disappeared. the patient was not given any treatment.  Action taken was not applicable.  It was not reported if the patient received a corrective treatment for the event.  At time of reporting, the outcome was Recovered / Resolved in May 2025 for the event.
Age: 40.0
Sex: F
Vaccine: PNC20
Symptoms: Chest X-ray, Pneumonia
Clinical narrative: Pneumonia
Age: 21.0
Sex: F
Vaccine: ANTH, HEPA, JEV1, UNK
Symptoms: Exposure during pregnancy, Pregnancy test urine positive
Clinical narrative: 21 yo service member presented to immunization for vaccines. Prior to her getting vaccines, Name, DOB, Allergies, any negative reactions, pregnancy status now or in the near future were all verified by one of the corpsman.  Patient answered Negative to all pre screener questions above. Post vaccination, Patient returned to immunization department requesting for pregnancy test due to uncertainly of her pregnancy status. Pregnancy test ordered and the result indicated positive for pregnancy. Pnt reported that her LMP was around 15APR2025 and she was not sure if she was pregnant or not. PCM CDR was reported and informed of patient, EDD: 20JAN2026
Age: 0.5
Sex: F
Vaccine: DTAPIPVHIB
Symptoms: Expired product administered
Clinical narrative: Pentacel was given past the expiration date with no reported adeverse event; Initial information received on 15-May-2025 regarding an unsolicited valid  non-serious case received from a other health professional.  This case involves a 6 months old female patient who was given Diphtheria/Tetanus/5 Hybrid Ac Pertussis/Ipv(Vero)/Hib(Prp/T) Vaccine [Pentacel (Vero)] past the expiration date with no reported adverse event.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   On 03-May-2025, the patient received 0.5mL of suspect Diphtheria/Tetanus/5 Hybrid Ac Pertussis/Ipv(Vero)/Hib(Prp/T) Vaccine, Suspension for injection (lot UK023AA, expiry date 30-APR-2025; strength not reported) for Immunization and was given past the expiration date with no reported adverse event (expired product administered) (latency same day).  Reportedly, caller reported that the Pentacel was given to 3 different patients past the expiration date. The first injection occurred on 03-May-2025, the second on 12-May-2025 and the last injection was on 14-May-2025.  Action taken was not applicable.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.; Sender's Comments:  US-SA-2025SA146684: US-SA-2025SA142769:
Age: 1.25
Sex: M
Vaccine: TDAP
Symptoms: No adverse event, Product administered to patient of inappropriate age
Clinical narrative: ADACEL was administered to a 15-month-6 days-old with no reported adverse event; Initial information received on 02-Jun-2025 regarding an unsolicited valid non-serious case received from a other health professional.  This case involves a 15 months 6 days old male patient who received Diphtheria-2/Tetanus/5 AC Pertussis Vaccine [Adacel] with no reported adverse event.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. Concomitant medications included Pneumococcal Vaccine for Immunisation.  On 22-May-2025, The patient received 0.5ml dose (Once) of suspect Diphtheria-2/Tetanus/5 Ac Pertussis Vaccine, Suspension for injection, Strength standard, lot U8252AA and expiry date 31-May-2026 via unknown route in the left thigh for immunization with no reported adverse event (product administered to patient of inappropriate age) (Latency same day).  Action taken was not applicable.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Age: 31.0
Sex: M
Vaccine: FLU3
Symptoms: Expired product administered
Clinical narrative: patient was administered with an expired FLUBLOK today, with no reported adverse event; Initial information received on 02-Jun-2025 regarding an unsolicited valid non-serious case received from a other health professional.  This case involves a 31 years old male patient who was administered with an expired influenza trivalent recombinant vaccine [flublok] today, with no reported adverse event.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  On 02-Jun-2025, the patient received a dose of 0.5 ml of expired suspect influenza trivalent recombinant vaccine, Solution for injection (lot TFAA2410 and expiry date 30-May-2025) (strength: standard and frequency: once) via intramuscular route in the left deltoid for immunization today with no reported adverse event (expired product administered) (Latency : same day)  Action taken was not applicable.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Sex: F
Vaccine: PNC21
Symptoms: Arthralgia, Decreased appetite, Fatigue, Peripheral swelling, Pyrexia
Clinical narrative: shoulder pain; arm swelling; fever of 104 degrees; fatigue; no appetite; rash; This spontaneous report was received from a 69-year-old female patient who was referring to herself. Her concurrent conditions included allergy to ciprofloxacin (CIPRO) and streptomycin sulfate (SEPTIN). The patient's medical history and concomitant therapies were not provided. On 02-MAY-2025, the patient was vaccinated with a dose of Pneumococcal 21-valent Conjugate Vaccine (CAPVAXIVE) (dose, route of administration, lot # and expiration date were not provided) for prophylaxis.  On the same day, she experienced shoulder pain, arm swelling, fever of 104 degrees (no exact units provided), fatigue, no appetite and a rash. On 09-MAY-2025, the patient recovered from the events. It was also reported that the fever lasted for 3 days (inconsistent information).  Causality assessment was not provided. Lot # is being requested and will be submitted if received.
Sex: F
Vaccine: PNC21
Symptoms: Rash
Clinical narrative: shoulder pain; arm swelling; fever of 104 degrees; fatigue; no appetite; rash; This spontaneous report was received from a 69-year-old female patient who was referring to herself. Her concurrent conditions included allergy to ciprofloxacin (CIPRO) and streptomycin sulfate (SEPTIN). The patient's medical history and concomitant therapies were not provided. On 02-MAY-2025, the patient was vaccinated with a dose of Pneumococcal 21-valent Conjugate Vaccine (CAPVAXIVE) (dose, route of administration, lot # and expiration date were not provided) for prophylaxis.  On the same day, she experienced shoulder pain, arm swelling, fever of 104 degrees (no exact units provided), fatigue, no appetite and a rash. On 09-MAY-2025, the patient recovered from the events. It was also reported that the fever lasted for 3 days (inconsistent information).  Causality assessment was not provided. Lot # is being requested and will be submitted if received.
Sex: F
Vaccine: HPV9, HPV9
Symptoms: Inappropriate schedule of product administration, No adverse event
Clinical narrative: a 37 year old female patient received her first dose of the GARDASIL 9 vaccine on 11/28/2023. The patient received her second dose of the GARDASIL 9 vaccine on 05/28/2025; No additional AE; Information has been received from Business Partner/CRO on 28-May-2025.  This spontaneous report was received from a/an Pharmacist and refers to a(n) 37-year-old female patient.   The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported.   On 28-Nov-2023, the patient started therapy with Human Papillomavirus 9-valent Vaccine, Recombinant (GARDASIL®9),, dose number 1, (first dose), administered by Unknown route (lot # and expiration date were not reported).  On 28-May-2025, the patient started therapy with Human Papillomavirus 9-valent Vaccine, Recombinant (GARDASIL®9),, dose number 2, (second dose), administered by Unknown route (lot # and expiration date were not reported). The patient started therapy with Human Papillomavirus 9-valent Vaccine, Recombinant (GARDASIL®9), for the treatment of prophylaxis.  On an unknown date, the patient experienced a 37 year old female patient received her first dose of the GARDASIL 9 vaccine on 11/28/2023. The patient received her second dose of the GARDASIL 9 vaccine on 05/28/2025. On an unknown date, the patient experienced No additional AE.   At the reporting time, the outcome of a 37 year old female patient received her first dose of the GARDASIL 9 vaccine on 11/28/2023. The patient received her second dose of the GARDASIL 9 vaccine on 05/28/2025 and No additional AE was unknown.   The action taken with Human Papillomavirus 9-valent Vaccine, Recombinant was reported as not applicable.
Vaccine: HEP
Symptoms: No adverse event, Product administered to patient of inappropriate age
Clinical narrative: No additional AE; an adult has been administered the child dose of RECOMBIVAX HB; This spontaneous report was received from a medical assistant and referred to an adult patient of unknown gender.   The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported.   On 05-MAY-2025, the adult patient was vaccinated with child dose of Hepatitis B Vaccine (Recombinant) (RECOMBIVAX HB) Injection (strength: 5 microgram/0.5 ml, lot # X024136, expiration date: 21-MAY-2026; dose, route and anatomical site were unknown) for prophylaxis (underdose). No additional adverse event (no adverse event). The outcome of the events was unknown.
Vaccine: COVID19, FLUN3
Symptoms: Body temperature, Dizziness, Dyspnoea, Feeling abnormal, Headache
Clinical narrative: a bit faint; headache; fever; nausea; Started feeling bad that evening; Shortness of breath; A spontaneous report has been received from a consumer. The report concerns a female adolescent patient (age 15 years).  No medical history was reported.   No concomitant products were reported.  The patient received Covid-19 Vaccine (batch number(s) 6024mf013), via intramuscular use for covid-19 immunization on 11-OCT-2024. The patient received 1 dose(s).  The patient started treatment with Flumist (flumist, influenza virus vaccine polyvalent, q/laiv) (batch number(s) WF2582) UNK, Nasal use, on 11-OCT-2024.   On 11-OCT-2024, the patient experienced a bit faint (preferred term: Dizziness),fever (preferred term: Pyrexia),headache (preferred term: Headache),nausea (preferred term: Nausea),shortness of breath (preferred term: Dyspnoea),started feeling bad that evening (preferred term: Feeling abnormal).      At the time of reporting, the event a bit faint, fever, headache, nausea, shortness of breath and started feeling bad that evening was improving.      The events were considered non-serious.   The reporter considered that there was a reasonable possibility of a causal relationship between Accuspray Single Dose and the following event(s): a bit faint, fever, headache, nausea, shortness of breath and started feeling bad that evening. The reporter considered that there was a reasonable possibility of a causal relationship between Covid-19 Vaccine and the following event(s): a bit faint, fever, headache, nausea, shortness of breath and started feeling bad that evening. The reporter considered that there was a reasonable possibility of a causal relationship between Flumist and the following event(s): a bit faint, fever, headache, nausea, shortness of breath and started feeling bad that evening.    Laboratory values are available.   ERROR F_ADDITIONAL_DEVICE_INFORMATION: ORA-01422: exact fetch returns more than requested number of rows
Vaccine: COVID19, FLUN3
Symptoms: Nausea, Pyrexia, SARS-CoV-2 test
Clinical narrative: a bit faint; headache; fever; nausea; Started feeling bad that evening; Shortness of breath; A spontaneous report has been received from a consumer. The report concerns a female adolescent patient (age 15 years).  No medical history was reported.   No concomitant products were reported.  The patient received Covid-19 Vaccine (batch number(s) 6024mf013), via intramuscular use for covid-19 immunization on 11-OCT-2024. The patient received 1 dose(s).  The patient started treatment with Flumist (flumist, influenza virus vaccine polyvalent, q/laiv) (batch number(s) WF2582) UNK, Nasal use, on 11-OCT-2024.   On 11-OCT-2024, the patient experienced a bit faint (preferred term: Dizziness),fever (preferred term: Pyrexia),headache (preferred term: Headache),nausea (preferred term: Nausea),shortness of breath (preferred term: Dyspnoea),started feeling bad that evening (preferred term: Feeling abnormal).      At the time of reporting, the event a bit faint, fever, headache, nausea, shortness of breath and started feeling bad that evening was improving.      The events were considered non-serious.   The reporter considered that there was a reasonable possibility of a causal relationship between Accuspray Single Dose and the following event(s): a bit faint, fever, headache, nausea, shortness of breath and started feeling bad that evening. The reporter considered that there was a reasonable possibility of a causal relationship between Covid-19 Vaccine and the following event(s): a bit faint, fever, headache, nausea, shortness of breath and started feeling bad that evening. The reporter considered that there was a reasonable possibility of a causal relationship between Flumist and the following event(s): a bit faint, fever, headache, nausea, shortness of breath and started feeling bad that evening.    Laboratory values are available.   ERROR F_ADDITIONAL_DEVICE_INFORMATION: ORA-01422: exact fetch returns more than requested number of rows
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Abortion spontaneous, Exposure during pregnancy
Clinical narrative: Miscarried 5 week pregnancy hours after injection.
Age: 72.0
Sex: M
Vaccine: PNC20
Symptoms: Injection site erythema, Injection site warmth, Pain in extremity, Peripheral swelling, Swelling face
Clinical narrative: Pt presented to office the day after his injection and was experiencing significant pain with mild swelling in his L hand (pt has arthritis in same location of hand), mild swelling to R cheek and mild redness/warmth at injection site. Seen by MD who dx with allergic rxn to vaccine (Pneumo vaccine entered as new allergy in medical record) and was prescribed 10 days of Prednisone 40mg daily. Pt had received 2 previous pneumococcal vaccines w/o issue: PPV 23 in October 2019 and PCV 13 in July 2021
Age: 26.0
Sex: M
Vaccine: COVID19
Symptoms: Angina pectoris, Attention deficit hyperactivity disorder, Brain fog, Condition aggravated, Dizziness
Clinical narrative: Whole body itching, yearly blood test indicating liver damage after vaccination, (no other reason for damage), severe ibs, severe symptoms of adhd.  extreme brain fog, dizziness, heart pains, extreme shortness of breath,
Age: 26.0
Sex: M
Vaccine: COVID19
Symptoms: Dyspnoea, Irritable bowel syndrome, Liver injury, Pruritus
Clinical narrative: Whole body itching, yearly blood test indicating liver damage after vaccination, (no other reason for damage), severe ibs, severe symptoms of adhd.  extreme brain fog, dizziness, heart pains, extreme shortness of breath,
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Blister, Injection site erythema, Injection site pain, Injection site swelling, Rash
Clinical narrative: Site: Pain at Injection Site-Severe, Site: Redness at Injection Site-Severe, Site: Swelling at Injection Site-Severe, Systemic: Rash/blisters on Right leg, neck, and chest-Severe, Additional Details: Patient states she awoke at 3am with a terrible stiff arm that she could not bend. She took 4 ibuprofen and about an hour later is was more tolerable, but then later on her right leg rashes and blisters appears, then appeared on her chest and neck also.  The leg rash went away within about a week, but the other rashes on her chest/neck took 6 weeks or more to resolve.
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Rash erythematous
Clinical narrative: Site: Pain at Injection Site-Severe, Site: Redness at Injection Site-Severe, Site: Swelling at Injection Site-Severe, Systemic: Rash/blisters on Right leg, neck, and chest-Severe, Additional Details: Patient states she awoke at 3am with a terrible stiff arm that she could not bend. She took 4 ibuprofen and about an hour later is was more tolerable, but then later on her right leg rashes and blisters appears, then appeared on her chest and neck also.  The leg rash went away within about a week, but the other rashes on her chest/neck took 6 weeks or more to resolve.
Age: 44.0
Sex: F
Vaccine: HEP
Symptoms: Dizziness, Fatigue, Injection site pain, Lethargy, Malaise
Clinical narrative: Site: Pain at Injection Site-Mild, Systemic: Dizziness / Lightheadness-Mild, Systemic: Exhaustion / Lethargy-Mild, Systemic: Fever-Mild, Additional Details: asked patient for another shot at drive through said previous shots made her very sick and that never happens and wont get any more shots., Other Vaccines:  VaccineTypeBrand: gardasil; Manufacturer: merk; LotNumber: y013469; Route: im; BodySite: right arm; Dose: ; VaxDate: UNKNOWN, VaccineTypeBrand: boostrix; Manufacturer: glaxcosmith; LotNumber: p63rp; Route: im; BodySite: left arm; Dose: ; VaxDate: UNKNOWN
Age: 44.0
Sex: F
Vaccine: HEP
Symptoms: Pyrexia
Clinical narrative: Site: Pain at Injection Site-Mild, Systemic: Dizziness / Lightheadness-Mild, Systemic: Exhaustion / Lethargy-Mild, Systemic: Fever-Mild, Additional Details: asked patient for another shot at drive through said previous shots made her very sick and that never happens and wont get any more shots., Other Vaccines:  VaccineTypeBrand: gardasil; Manufacturer: merk; LotNumber: y013469; Route: im; BodySite: right arm; Dose: ; VaxDate: UNKNOWN, VaccineTypeBrand: boostrix; Manufacturer: glaxcosmith; LotNumber: p63rp; Route: im; BodySite: left arm; Dose: ; VaxDate: UNKNOWN
Age: 73.0
Sex: F
Vaccine: RSV
Symptoms: Injection site rash, Injection site swelling, Injection site warmth, Rash erythematous
Clinical narrative: Site: Redness at Injection Site-Medium, Site: Swelling at Injection Site-Medium, Additional Details: developed a red hot rash 2 days after injection..2 inches in diameter..self-resolved
Age: 80.0
Sex: M
Vaccine: VARZOS
Symptoms: Asthenia, Chest discomfort, Chest pain, Dizziness
Clinical narrative: Systemic: Chest Tightness / Heaviness / Pain-Mild, Systemic: Dizziness / Lightheadness-Mild, Systemic: weak-Mild
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Systemic: Fever-Medium
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Systemic: Fever-Medium
Age: 76.0
Sex: F
Vaccine: VARZOS
Symptoms: Chills, Flushing, Headache, Hyperhidrosis, Injection site pruritus
Clinical narrative: Site: Itching at Injection Site-Mild, Systemic: Allergic: Itch (specify: facial area, extremeties)-Mild, Systemic: Allergic: Rash (specify: facial area, extremeties)-Mild, Systemic: Chills-Mild, Systemic: Fever-Mild, Systemic: Flushed / Sweating-Mild, Systemic: Headache-Mild, Additional Details: Symptoms did not get worse, patient taking benadryl to combat rash near elbow and face ( itchy eyes), Other Vaccines:  VaccineTypeBrand: TDAP boostrix; Manufacturer: glaxosmithkline; LotNumber: PG3RP; Route: IM; BodySite: Left deltoid; Dose: ; VaxDate: UNKNOWN
Age: 76.0
Sex: F
Vaccine: VARZOS
Symptoms: Pruritus, Pyrexia, Rash
Clinical narrative: Site: Itching at Injection Site-Mild, Systemic: Allergic: Itch (specify: facial area, extremeties)-Mild, Systemic: Allergic: Rash (specify: facial area, extremeties)-Mild, Systemic: Chills-Mild, Systemic: Fever-Mild, Systemic: Flushed / Sweating-Mild, Systemic: Headache-Mild, Additional Details: Symptoms did not get worse, patient taking benadryl to combat rash near elbow and face ( itchy eyes), Other Vaccines:  VaccineTypeBrand: TDAP boostrix; Manufacturer: glaxosmithkline; LotNumber: PG3RP; Route: IM; BodySite: Left deltoid; Dose: ; VaxDate: UNKNOWN
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Headache, Lethargy
Clinical narrative: Systemic: Exhaustion / Lethargy-Medium, Systemic: Headache-Medium
Age: 57.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Headache, Lethargy
Clinical narrative: Systemic: Exhaustion / Lethargy-Medium, Systemic: Headache-Medium
Age: 76.0
Sex: M
Vaccine: VARZOS
Symptoms: Injection site pain, Product administered at inappropriate site
Clinical narrative: Site: Pain at Injection Site-Severe, Additional Details: Patient says the shot was administered too high on the shoulder but did not go to doctor or er to have examined. He said the severe pain in his shoulder kept him from daily activities for 3 days.
Age: 85.0
Sex: F
Vaccine: COVID19
Symptoms: Depressed mood, Injection site pain
Clinical narrative: Site: Pain at Injection Site-Mild, Additional Details: Caregiver reports that patient experienced injection sit soreness for about 5-6 days after receiving the vaccine. The pain started the day after the vaccine was administered. She also seemed to feel down for 3-4 days after the vaccine
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Systemic: Fever-Mild
Age: 82.0
Sex: F
Vaccine: COVID19
Symptoms: Injected limb mobility decreased, Injection site pain
Clinical narrative: Site: Pain at Injection Site-Severe, Additional Details: patient mentioned it took 4 hours after vaccination to be able to lift arm and a few weeks to be able to move arm regularly and fully recover
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Influenza like illness, Injection site pain, Lethargy, Pain
Clinical narrative: Site: Pain at Injection Site-Mild, Site: Swelling at Injection Site-Severe, Systemic: Exhaustion / Lethargy-Medium, Additional Details: Patient stated she felt flu like symptoms, lethargic, ache for a few days and her arm was swollen and tender for over a month. She has fully recovered
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Peripheral swelling, Tenderness
Clinical narrative: Site: Pain at Injection Site-Mild, Site: Swelling at Injection Site-Severe, Systemic: Exhaustion / Lethargy-Medium, Additional Details: Patient stated she felt flu like symptoms, lethargic, ache for a few days and her arm was swollen and tender for over a month. She has fully recovered
Age: 83.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Injection site swelling, Laboratory test abnormal, Magnetic resonance imaging abnormal, Pain in extremity
Clinical narrative: Site: Swelling at Injection Site-Medium, Systemic: Progressive pain beginning in feet, traveling up legs into spine and shoulders-Severe, Systemic: Joint Pain-Severe, Additional Details: Patient had progessively worsening pain, abnormal lab values and MRI. Has seen specialists with no specific diagnosis.
Age: 83.0
Sex: M
Vaccine: COVID19
Symptoms: Spinal pain
Clinical narrative: Site: Swelling at Injection Site-Medium, Systemic: Progressive pain beginning in feet, traveling up legs into spine and shoulders-Severe, Systemic: Joint Pain-Severe, Additional Details: Patient had progessively worsening pain, abnormal lab values and MRI. Has seen specialists with no specific diagnosis.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Systemic: Fever-Mild, Additional Details: Patient did not give more information as to which vaccine and said just gets a fever after vaccines-tech called for covid
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Influenza like illness
Clinical narrative: Systemic: Flu like symptoms-Medium, Systemic: Weakness-Medium
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Bladder cancer
Clinical narrative: Systemic: Patient says he has bladder cancer and is undergoing treatment-Severe, Additional Details: Patient says he has bladder cancer and is undergoing treatment
Age: 69.0
Sex: F
Vaccine: VARZOS
Symptoms: Arthralgia, Injection site pain, Pain
Clinical narrative: Site: Pain at Injection Site-Medium, Systemic: Joint Pain-Medium, Additional Details: Patient presented at the pharmacy and received vaccine 55 days ago. Still having pain in her arm. Patient is able to lift arm but notices pain with some movement. Patient is following up with physician.
Age: 20.0
Sex: M
Vaccine: COVID19
Symptoms: Dizziness, Dizziness postural, Flushing, Headache, Heart rate decreased
Clinical narrative: Systemic: Dizziness / Lightheadness-Mild, Systemic: Fainting / Unresponsive-Medium, Systemic: Flushed / Sweating-Mild, Systemic: Headache-Mild, Systemic: Hypotension-Mild, Systemic: Nausea-Mild, Additional Details: Immediately after needle inserted during COVID-19 vaccination, patient became pale, his head fell backward & he lost consciousness. Vaccine was administered & provider able to keep patient in chair & safe. Patient regained consciousness approximately 10 seconds later after several hard sternal rubs & name shouting. Pt diaphoretic & nauseated with low HR & BP for about 5 minutes; VSS by 0901. Provider had pt call someone to drive him home due to syncope, even though VS had returned to normal
Age: 20.0
Sex: M
Vaccine: COVID19
Symptoms: Hyperhidrosis, Hypotension, Immediate post-injection reaction, Loss of consciousness, Nausea
Clinical narrative: Systemic: Dizziness / Lightheadness-Mild, Systemic: Fainting / Unresponsive-Medium, Systemic: Flushed / Sweating-Mild, Systemic: Headache-Mild, Systemic: Hypotension-Mild, Systemic: Nausea-Mild, Additional Details: Immediately after needle inserted during COVID-19 vaccination, patient became pale, his head fell backward & he lost consciousness. Vaccine was administered & provider able to keep patient in chair & safe. Patient regained consciousness approximately 10 seconds later after several hard sternal rubs & name shouting. Pt diaphoretic & nauseated with low HR & BP for about 5 minutes; VSS by 0901. Provider had pt call someone to drive him home due to syncope, even though VS had returned to normal
Age: 20.0
Sex: M
Vaccine: COVID19
Symptoms: Pallor, Syncope, Unresponsive to stimuli
Clinical narrative: Systemic: Dizziness / Lightheadness-Mild, Systemic: Fainting / Unresponsive-Medium, Systemic: Flushed / Sweating-Mild, Systemic: Headache-Mild, Systemic: Hypotension-Mild, Systemic: Nausea-Mild, Additional Details: Immediately after needle inserted during COVID-19 vaccination, patient became pale, his head fell backward & he lost consciousness. Vaccine was administered & provider able to keep patient in chair & safe. Patient regained consciousness approximately 10 seconds later after several hard sternal rubs & name shouting. Pt diaphoretic & nauseated with low HR & BP for about 5 minutes; VSS by 0901. Provider had pt call someone to drive him home due to syncope, even though VS had returned to normal
Age: 25.0
Sex: F
Vaccine: HEP
Symptoms: Hypoaesthesia, Injection site pain, Joint injury, Paraesthesia, Product administered at inappropriate site
Clinical narrative: Site: Pain at Injection Site-Medium, Systemic: Numbness (specify: facial area, extremities)-Medium, Systemic: Tingling (specify: facial area, extemities)-Medium, Error: Shoulder Joint Injury (prolonged pain, tingling, etc.)-, Additional Details: Numbness that starts at neck and radiates down to fingertips. Patient states vaccine was administered high in arm near shoulder
Age: 67.0
Sex: M
Vaccine: VARZOS
Symptoms: Hypoaesthesia
Clinical narrative: Systemic: Numbness (specify: facial area, extremities)-Mild, Additional Details: patient stated that his pinkie went numb after receiving shot. stated that after a few minutes the numbness spread
Age: 17.0
Sex: F
Vaccine: MNQ
Symptoms: Loss of consciousness, Seizure, Syncope, Unresponsive to stimuli
Clinical narrative: Systemic: Fainting / Unresponsive-Mild, Systemic: Seizure-Mild, Additional Details: 2-3 minutes after immunization, patient fainted and starting seizing in her chair. regained consciousness after a few seconds.
Age: 78.0
Sex: F
Vaccine: COVID19-2
Symptoms: Asthenia, Hypotension, Injection site pain, Orthostatic intolerance
Clinical narrative: Site: Pain at Injection Site-Mild, Systemic: feeling week and orthostatic-Medium, Systemic: Hypotension-Medium, Systemic: Weakness-Medium, Other Vaccines:  VaccineTypeBrand: prevnar 20; Manufacturer: pfizer; LotNumber: lw1951; Route: IM; BodySite: left Arm; Dose: 1; VaxDate: 05/31/2025
Age: 17.0
Sex: M
Vaccine: MNQ
Symptoms: Dizziness, Hyperhidrosis, Pallor
Clinical narrative: Patient became pale, lightheaded and sweaty. "Feel like im going to pass out".
Age: 78.0
Sex: M
Vaccine: PNC21
Symptoms: Rash, Swelling
Clinical narrative: Patient reported mild rash and swelling that extended down arm, appearing approximately 12-18 hours after vaccine and continued for about 3 days before abating. Patient reports no further adverse effects after event. Patient advised to watch for any further signs or symptoms and report as needed.
Age: 60.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Cough, Diarrhoea, Fatigue, Pain, SARS-CoV-2 test
Clinical narrative: Fatigue, body aches x4-5 days, cough, diarrhea
Age: 43.0
Sex: F
Vaccine: TDAP
Symptoms: Axillary pain, Breast pain, Injection site erythema, Limb discomfort, Oedema peripheral
Clinical narrative: Right arm heaviness/swelling that started day after receiving vaccine and lasted 2 weeks. Reports pain/swelling went into right axilla and had right breast pain. Also reports some redness at site of vaccine. Symptoms resolved after 2 weeks and asymptomatic at this time. Took Tylenol for symptom relief - did not report adverse event until after symptoms had resolved.
Age: 43.0
Sex: F
Vaccine: TDAP
Symptoms: Peripheral swelling
Clinical narrative: Right arm heaviness/swelling that started day after receiving vaccine and lasted 2 weeks. Reports pain/swelling went into right axilla and had right breast pain. Also reports some redness at site of vaccine. Symptoms resolved after 2 weeks and asymptomatic at this time. Took Tylenol for symptom relief - did not report adverse event until after symptoms had resolved.
Age: 17.0
Sex: M
Vaccine: TYP
Symptoms: Pain in extremity, Pruritus, Urticaria
Clinical narrative: Per client's mom: Client took first capsule 5/25/25, took second capsule 5/27/25, complained he thought his new shower gel was making his skin itchy. Took third capsule 5/29/25, started with hives. Over the next several days hives broke out systemically-hips, abdomen, lips, feet. Client complained of sore feet. Client has taken benadryl and zyrtec,and was seen at an urgent care office 6/3/25.
Age: 24.0
Sex: M
Vaccine: MMR
Symptoms: Antibody test abnormal, Extra dose administered
Clinical narrative: Patient came into the clinic and presented low titer for MMR. Patient requested an additional dose of MMR due the titer being low and needing another dose due to college.  Nurse administered additional MMR dose due to low titer.
Age: 52.0
Sex: F
Vaccine: TDAP, UNK
Symptoms: Erythema, Pain, Pain in extremity, Peripheral swelling, Pruritus
Clinical narrative: Her right upper arm swelled, became red and hot, felt itchy, and was mildly painful to movement. She presented to urgent care on 5/24/25 and was diagnosed with a local reaction to the vaccines and treated with a Medrol Dospak
Age: 52.0
Sex: F
Vaccine: TDAP, UNK
Symptoms: Skin warm
Clinical narrative: Her right upper arm swelled, became red and hot, felt itchy, and was mildly painful to movement. She presented to urgent care on 5/24/25 and was diagnosed with a local reaction to the vaccines and treated with a Medrol Dospak
Age: 35.0
Sex: M
Vaccine: RAB
Symptoms: Eye swelling, Lip swelling, Rash, Rash macular, Urticaria
Clinical narrative: 10 days post vaccination, woke up with swollen lips and eyes with red splotches over face, neck, trunk, arms, palms, thighs (none below knee).  Went to  urgent care and was given IM steroid dose and steroid dose pak prescription.  Things were improving and clearing but at day 3 of steroid pak, is noticing recurrence of swelling to lips and rash over arms and trunk,  and urticaria.
Age: 20.0
Sex: M
Vaccine: UNK, UNK, UNK
Symptoms: Dyspnoea, Ear swelling, Fatigue, Pharyngeal swelling, Rash
Clinical narrative: Patient visited the clinic for immunizations prior to travel. He received Yellow Fever, Typhoid and Tdap vaccines at approximatly 10:00 am and remainded in the exam room for another 20 minutes with no signs/symptoms of asdverse effects. He phoned the facility at 2:10 pm and left a voice mail that he was experiencing difficulty breathing, rash, all over, and a feeling of his ears and throat swelling and asked what he should do. A nurse returned his call at 2:20 pm and recommended patient go to ER. His father stated he was on the way at that time. He was treated with Epinephrine, Benadryl, and Pepcid and observed for 2 hours. Upon discharge he was prescriobed Pepcid, Prednisone and Benadryl for four days and instructed to return to the ER with futher symptoms. I called him this morning and he states he was very tired, but feeling better..
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Autoimmune hepatitis, Chest discomfort, Dyspnoea, Hypertension, Iron overload
Clinical narrative: Chest pressure, shortness of breath, hypertension. Frozen shoulder. Autoimmune Hepatitis. Iron overload.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Periarthritis
Clinical narrative: Chest pressure, shortness of breath, hypertension. Frozen shoulder. Autoimmune Hepatitis. Iron overload.
Age: 0.67
Sex: F
Vaccine: MMR
Symptoms: Rash
Clinical narrative: Child broke out in full body rash day 3 after vaccine administration including, head, trunk, legs, and arms
Age: 55.0
Sex: M
Vaccine: FLU3
Symptoms: Blister, Bradykinesia, Injection site pain, Muscular weakness, Pain in extremity
Clinical narrative: Burn like rash around eyes, all the way down around my face and around mouth. Severe burning with small blisters. Small bumps still remain around eyes, never went away. Severe pain around injection site going all the way down arm. Weakened use of right hand, slowed hand response. Pain still persists.
Age: 55.0
Sex: M
Vaccine: FLU3
Symptoms: Perioral dermatitis, Rash, Skin burning sensation
Clinical narrative: Burn like rash around eyes, all the way down around my face and around mouth. Severe burning with small blisters. Small bumps still remain around eyes, never went away. Severe pain around injection site going all the way down arm. Weakened use of right hand, slowed hand response. Pain still persists.
Age: 54.0
Sex: F
Vaccine: PNC20
Symptoms: Injection site erythema, Injection site induration, Injection site pain, Injection site swelling
Clinical narrative: AT INJECTION SITE, REDNESS, PAIN, SWELLING, HEAT, AND A HARDENED AREA THAT HAS NOW CIRCLED TO INNER ASPECT OF LOWER LEFT ARM UNDER ELBOW